Finally, tetrandrine is a bisbenzylisoquinoline alkaloid, whose anti-cancer activity has been demonstrated to inhibit PI3K/Akt signaling by upregulating TGF-β1 and reduce PTEN phosphorylation (173). This evidence concerns the gene PTEN and cancer.